Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3774_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
20 Мб
Скачать
3 Mechanisms oftheVulnerable Atherosclerotic Plaque andImaging
https://t.me/medicina_free
51
3.3 Plaque Erosion
Plaque erosions account for approximately one-third of lesions causing ACS [32,
33]. Plaque erosion is dened by the presence of a thrombus in direct contact with
the intima, with absent endothelium and no identiable brous cap rupture [34]. In contrast to plaque rupture, the underlying intima is rich in smooth muscle cells and proteoglycans and has minimal inammatory cell inltrate [5]. Erosions are also associated with a smaller plaque and necrotic core area, and lesser stenosis and plaque burden than ruptures [35].
Plaque erosions are more common in younger men and women (<50-years-old) and are associated with smoking, particularly in premenopausal women [5, 34]. Additionally, optical coherence tomography (OCT) studies have revealed that non­ ST elevated acute coronary syndromes (NSTEACs) are more commonly associated with OCT-erosions and OCT-calcied nodules than ruptures [32].
The mechanism of plaque erosion has not been precisely elucidated. Proposed mechanisms involve a complex simultaneous interplay between processes causing endothelial cell loss, neutrophil recruitment, and thrombosis [36]. The underlying intima in plaque erosions is rich in smooth muscle cells and proteoglycans. Hyaluronan, a component of proteoglycans, has been shown to increase Toll-like receptor- 2 (TLR-2) expression invivo. Additionally, erosions causing locally dis­turbed blood ow can increase endothelial TLR-2 expression and apoptosis [37]. Increased TLR-2 expression may lead to the accumulation of neutrophils, endothe­lial cell apoptosis and thrombosis.
3.4 Calcied Nodules
A calcied nodule is the least common cause of thrombosis [34]. Calcied nodules can disrupt the overlying brous cap and cause thrombosis, however, it is not a com­mon occurrence [5]. In an OCT study of 126 ACS patients, calcied nodules had an incidence of 7.9% [32]. They are more commonly seen in elderly individuals with heavily calcied arteries and most frequently found in the mid-right coronary artery [5]. In the PROSPECT study, calcied nodules identied with intravascular ultra­sound (IVUS) resulted in very few coronary events at 3years follow up [38].
3.5 Effect ofDiabetes onPlaque Morphology
Diabetes in patients without clinical CAD is associated with an atherosclerotic burden equivalent to that of non-diabetics with clinical CAD, hence diabetes is thought to be a ‘CAD equivalent’ in terms of risk factors. Differences in plaque morphology have been shown between diabetic and non-diabetic patients. Diabetes has been associated with more widespread diffuse atherosclerosis, increased calcication [39], increased inammatory inltrate (macrophage,
52
https://t.me/medicina_free
T-cells), HLA-DR expression [40], CRP elevation, larger necrotic core, greater number of healed plaques [41], and increased presence of TCFAs [42, 43]. The underlying cellular mechanisms behind this are multifactorial. Autopsy studies have shown increased expression of receptors for advanced glycated end-prod­ucts (RAGE) and RAGE-binding protein in plaques of diabetic patients. Hyperglycaemia can result in increased production of advanced glycated end­products (AGE) and AGE/RAGE signaling has been linked to increased calcica­tion, oxidative stress and vascular inammation, thereby contributing to accelerated atherosclerosis [41, 44].
K. Rana et al.
3.6 Carotid Imaging
3.6.1 Carotid Ultrasound
Intraplaque haemorrhage and the lipid-rich necrotic core appear echolucent on ultrasound. Both of these plaque features cannot be distinguished on ultrasound. Echolucent plaques are associated with an increased rate of cerebrovascular events, independent of the degree of stenosis or cardiovascular risk factors [45, 46].
The grayscale median (GSM) score is a standardised way of characterising plaques. The more echogenic the plaque, the higher the GSM score. GSM mea­surements can be made from a single longitudinal view (SLV-GSM) or from mul­tiple cross-sectional views (MCSV-GSM). Plaques with a lower GSM score (i.e. echolucent plaques) have been associated with an increased risk of stroke [47,
48]. In one study, the incidence of stroke was 9% for plaques with a GSM >50 and
40% in those with a GSM <50 (p < 0.001) [49]. Another study distinguished plaques causing amaurosis fugax from asymptomatic plaques by the GSM fea­tures of increased plaque heterogeneity (highest MCSV-GSM minus the lowest MCSV-GSM) and increased echolucency in plaques associated with amaurosis fugax [50].
Plaque calcication and the brous cap appear echogenic on ultrasonography. Ultrasonographic brous cap thickness measurement has shown to have excellent correlation with histological ndings [51]. The Oxford plaque study showed that ruptured carotid plaques had a median representative cap thickness of 300μm and a median minimum cap thickness of 150μm, compared to 500 μm and 250μm for non-ruptured plaques respectively [52]. This study proposed a representative cap thickness of less than 500μm and minimum cap thickness of less than 200μm to identify ruptured plaques on carotid ultrasonography.
Plaque ulceration is dened as an area of surface irregularity in the plaque­lumen border greater than 2mm in depth and with a well-dened back wall at its base [53]. Standard and Doppler ultrasonography have a low sensitivity and speci­city to detect plaque ulceration when compared with CT and MRI [54, 55], how­ever contrast- enhanced ultrasonography has been shown to have improved
Mechanisms oftheVulnerable Atherosclerotic Plaque andImaging
https://t.me/medicina_free
3
Table 3.1 The detection of vulnerable plaque features by ultrasound
Morphological features Ultrasound ndings
Intraplaque haemorrhage and large lipid-rich necrotic core (LR-NC)
Thin brous cap Echogenic brous cap with minimum cap
Plaque ulceration Surface irregularity >2mm depth, well-dened
Neovascularisation Enhancement with contrast
Echolucent plaque
thickness <200μm
back wall on colour doppler
53
sensitivity and accuracy for the detection of plaque ulceration when compared to standard ultrasound [56].
Plaque neovascularisation and inammation are active processes implicated in plaque rupture. However, these processes are unable to be evaluated by simple B-mode ultrasonography. Contrast-enhanced ultrasonography can however use an intravenous microbubble agent that remains within the vascular space to enhance areas of neovascularisation and inammation in the plaque [57]. Contrast enhance­ment indicating neovascularisation was seen in more than 93% of soft, echolucent plaques [58]. These ultrasonography features may be used for the risk stratication of carotid plaques (Table3.1).
Doppler imaging can be used to assess the haemodynamic signicance of inter­nal carotid artery (ICA) lesions. The ICA peak systolic velocity (PSV) and the visualisation of plaque on B-mode or Doppler are key determinants for the grading of lesions. The Society of Radiologists has published consensus guidelines on the grading of carotid artery lesions with ultrasonography [59]. The ICA/CCA ratio and end diastolic velocity (EDV) are additional measurements used to assist in grading lesions. The ICA is normal when PSV is <125cm/s and there is no plaque visualised; there is <50% stenosis when PSV is <125cm/s and there is plaque or intimal thickening visible; 50–69% stenosis is present when PSV is between 125 and 230cm/s and plaque is visible; >70% stenosis when PSV is >230 cm/s and visible plaque and luminal narrowing is seen; near-occlusion is when there is “trickle” ow on colour Doppler and total occlusion is when there is no detectable lumen on B-mode ultrasound and no detectable ow on Doppler imaging [59]. It should be noted that there is not a linear association between PSV and the degree of stenosis—for a near-occlusion or complete occlusion, the PSV may be low or undetectable.
3.6.2 Carotid Computed Tomography
Multidetector-row CT (MDCT) and dual-source CT (DSCT) are the two main CT modalities used for carotid plaque imaging. Both techniques provide a high spatial and temporal resolution and can be used for plaque characterisation.
54
https://t.me/medicina_free
K. Rana et al.
CT angiography (CTA) of the carotid arteries has a higher spatial resolution and quicker acquisition time than magnetic resonance angiography (MRA) [60]. CTA can provide information on the degree of luminal narrowing, as well as plaque mor­phological features including plaque calcication, brous cap thickness, intraplaque haemorrhage and lipid-rich necrotic core [60]. Comparison of carotid CTAs with histological examination of endarterectomy specimens has allowed for the correla­tion of different plaque features with CT Hounseld densities [61]. Calcications are readily identied due to their high density (HU >250). There is a signicant degree of overlap between the CT Hounseld densities of lipid-rich necrotic core (LR-NC) and connective tissue, as well as some overlap between connective tissue and haemorrhage. However, as a general rule, LR-NC has a low density (HU<30) whilst connective tissue and haemorrhage have an intermediate density (between 30 and 150HU) (Fig.3.2).
CTA does, however, show good reliability when considering large (>5-pixels) LR-NC and haemorrhages. CTA is also reliable in detecting ulcerations as small as 1mm and measuring the brous cap thickness [61]. Fibrous cap thickness measure­ment on CTA was found to have excellent correlation with histological examination
ab c
Fig. 3.2 Computed tomography (CT) imaging of Carotid Plaque. CT reconstruction (a) and vol­ume rendering (b) showing a wide ulcerated carotid plaque causing signicant stenosis. CTA axial image (c) shows a hypodense plaque (white arrow). Histological section (d) reveals the presence of neovessels (black arrows) and macrophages (black arrowheads). (Reprinted from Saba, Anzidei [106])
d
Mechanisms oftheVulnerable Atherosclerotic Plaque andImaging
https://t.me/medicina_free
3
55
(P<0.001) [61]. Additionally, carotid plaque enhancement with contrast agents has shown good correlation with intraplaque neovascularisation [62].
Plaque features derived from CTA have shown to be correlated with cerebrovas­cular events including strokes and TIAs. A higher risk of stroke was found with the following features on CTA in one study: an increased wall volume, a thinner brous cap, higher number of lipid clusters, lipid clusters closer to the lumen, and fewer calcium clusters [63]. Other studies have also shown a correlation between non­calcied plaques or plaques with calcication at their base [64], carotid plaque enhancement [62] and ssured brous caps [65] with cerebrovascular events. Plaque morphological features derived from CTA can assist in determining the risk of future cerebrovascular events. Interventions may be directed at those deemed to be at high risk, however further studies are needed in this area.
3.6.3 Carotid Magnetic Resonance Imaging
Carotid MRI enables accurate visualisation of vulnerable carotid plaque features including thin or ruptured brous caps, large lipid-rich necrotic core, intraplaque haemorrhage, and carotid wall thickness. These features are associated with an increased risk of future cerebrovascular events [66].
Histological correlation of endarterectomy specimens with carotid MRI features has led to the development of a tissue type classication system linking MRI features to the histological ndings (Table3.2, Fig.3.3). The lipid-rich necrotic core is seen centrally and forms the bulk of the plaque. A lipid-rich necrotic core may be seen with or without intraplaque haemorrhage (IPH). The intensities of IPH vary depend­ing on whether it is acute (<1week), recent (1–6weeks), or old (>6weeks) [67].
Table 3.2 Correspondence of plaque features with invivo MRI ndings
Plaque features
LR/NC with no IPH
LR/NC with IPH—Fresh
LR/NC with IPH—Recent
LR/NC with IPH—Old
Calcication Hypointense Hypointense Hypointense Hypointense Dense brous
tissue Loose matrix Hypo/isointense Hyperintense Hyperintense Hypointense
LR/NC lipid rich necrotic core, IPH intraplaque haemorrhage Chu, Kampschulte [67], Saam, Ferguson [112]
T1-weighted sequence
Iso/hyperintense Hypo/isointense Iso/hyperintense Isointense
Hyperintense Hypointense/
Hyperintense Hyperintense Hyperintense Hyperintense
Hypointense Hypointense Hypointense Hypointense
Isointense Isointense Isointense Hypointense
T2-weighted sequence
isointense
Proton density­weighted sequence
Hypointense/ isointense
Time of ight
Hyperintense
56
https://t.me/medicina_free
K. Rana et al.
a
b
Fig. 3.3 T1-weighted (T1W) and time of ight (TOF) section through a left internal carotid artery lesion. Baseline imaging (a) and follow-up imaging at 18months (b). The lesion contains intra­plaque haemorrhage (arrow heads) and calcications (arrows). A reduction in lumen area and increased wall thickness can be seen from (a–b). JV jugular vein. Lumen of the internal carotid. (Reprinted from Underhill, Yuan [107])
Gadolinium-based contrast agents can be administered intravenously in carotid MRIs. The gadolinium enhances areas with increased vascularity. Thus, contrast-enhanced magnetic resonance imaging (CEMRI) can be used to help differentiate the brous cap which becomes enhanced, from the poorly vascula­rised LR-NC which does not enhance. CEMRI allows for quantication of the plaque volume, brous cap thickness and LR-NC—important determinants of plaque vulnerability [68]. Additionally, the rate of contrast enhancement is sig­nicantly correlated with neovascularisation and macrophage content. Thus, carotid MRIs can provide detailed information on the features of a vulnerable plaque. But how do these imaging technologies correlate with the risk of future clinical events?
3 Mechanisms oftheVulnerable Atherosclerotic Plaque andImaging
https://t.me/medicina_free
57
MRI allows for the visualisation of high-risk plaque features that are not detect­able on standard carotid ultrasonography. High-risk plaque features derived from MRI including IPH, large LR-NC and thin/ruptured brous caps have been associ­ated with an increased risk of future ipsilateral ischaemic events [66, 69]. Detailed information on plaque morphology may allow clinicians to monitor high-risk plaque features and their response to medical therapy, as well as providing new indications for medical and/or surgical therapy directed at high-risk plaques that may not be symptomatic or signicantly obstructive. Conversely, moderate stenoses (50–70%) on Doppler ultrasonography which do not have high-risk plaque features on MRI are reassuring markers of plaque stability and hence aid in clinical decision making.
3.7 Molecular Imaging
Positron emission tomography (PET) scans can be used to image functional pro­cesses implicated in atherosclerosis and plaque rupture. PET scans involve the administration of positron-emitting isotopes which decay resulting in the produc­tion of two photons that travel in opposite directions. The photons are detected and used to produce an image reecting the location and density of the isotopes.
3.7.1 Imaging Inammation: Fluorodeoxyglucose (18F-FDG)
Fluorodeoxyglucose (18F-FDG) is a radioactive glucose analogue that accumulates in cells in direct proportion to their rate of glycolysis and hence is a marker of glu­cose metabolism. In atherosclerosis, 18F-FDG can be exploited as a marker of mac­rophage activity (Fig. 3.4) [70, 71]. Histological studies have shown that the intensity of endarterectomy specimens [71, 72]. Increased macrophage activity predominantly reects the degree of inammation in the plaque (Fig.3.5) [70, 71]. However, there are also other factors that contribute to an increased signal. Hypoxia in atheroscle­rotic plaques can stimulate neoangiogenesis, glucose uptake by macrophages, and inammation causing an increase in glycolysis and accumulation of 18F-FDG [73,
74]. The 18F-FDG signal may also be impacted by delivery. Increased microvascular
permeability and microvessel density may increase delivery of 18F-FDG and thus the signal may not entirely reect the degree of inammation [75].
Clinically, the utility of 18F-FDG has not been well dened, however studies have shown promise. 18F-FDG scans have been shown to help in predicting early stroke recurrence [76], cardiovascular events in a cohort with neoplastic disease [77], and can help predict the risk of cardiovascular disease beyond the Framingham risk score in some populations [78]. However, metabolism and can be taken up by the myocardium, making it difcult to clearly assess the signals from the coronary arteries [70].
18
F-FDG uptake correlates well with the macrophage content of plaque
18
F-FDG is a non-specic marker of
58
Large Necrotic Core
T1-weighted High Intensity
Black Blood Imaging
p
https://t.me/medicina_free
Late Gadolinium Enhancement
Macrophage
Infiltration
USPIOs
18F-FDG PET/MRI
Microcalcification
18F-fluoride PET/MRI
Angiogenesis &
Intraplaque Hemorrhage
Plaque Imaging
Fig. 3.4 Vulnerable plaque features on MRI.Vulnerable plaque features that can be detected with magnetic resonance imaging. (Reprinted from Dweck, Puntman [108])
Positive Remodeling
T1-weighted
K. Rana et al.
Thin Fibrous Ca
Sub-clinical
Plaque Rupture
T1-weighted
High Intensity
Plaque Imaging
18
F-FDG imaging has also been shown to play a role in assessing the clinical util­ity of drugs to reduce inammation in plaques. A FDG-PET study provided evi­dence for dose-dependent reductions in carotid plaque 18F-FDG uptake with statin therapy, independent of changes in blood lipid proles [71]. This study showed that patients randomized to atorvastatin 80mg had signicantly reduced inammation in the index vessel as compared to patients randomized to atorvastatin 10mg at 12-weeks [71]. Additionally, 18F-FDG imaging can be used as an endpoint in clini­cal trials to test the efcacy of various anti-atherosclerotic or anti-inammatory drugs for atherosclerosis.
3.7.2 Imaging Microcalcication: Sodium Fluoride (18F-NaF)
Spotty (micro) calcication is a feature of vulnerable plaques, whereas dense mac­rocalcication is associated with stable plaques [30]. Microcalcication cannot be detected with plain CT-scans whilst macrocalcication can be detected on CT.Sodium uoride ( tions that were previously not detectable on plain CT. NaF is incorporated into hydroxyapatite at sites of active calcication [79]. It has traditionally been used to image bone diseases and cancers, however its application is now being extended
18
F-NaF) is a promising isotope that can help image calcica-
a
a
b
Mechanisms oftheVulnerable Atherosclerotic Plaque andImaging
https://t.me/medicina_free
3
59
b
c
Fig. 3.5 Molecular imaging of vulnerable plaque with Fluorodeoxyglucose (left panels) and Sodium Fluoride (NaF) (right panels). (Left panels) Fluorodeoxyglucose (FDG) uptake as a marker of plaque inammation. subjects with Coronary Artery Disease (CAD). F-FDG imaging in a patient with recent ACS and a new stent (a) indicates a higher degree of tracer uptake than those with a stable syndrome and a new or old stent (b, c). (d) shows Syndrome (ACS) patient. Reprinted from Rogers, Nasir [109]. (Right panels) Sodium Fluoride (NaF) as a marker of active plaque calcication. activity in CAD patients. (a) Control subject with no calcication or NaF uptake. (b) Subject had extensive calcication in the left anterior descending artery as demonstrated by the hyperdense lesions however had no NaF uptake, indicating no current active calcication processes. (c) Shows increased NaF uptake on top of existing calcication. (d) Shows increased NaF uptake in the LAD adjacent to existing calcication. (Reprinted from Dweck, Chow [
d
18
F-FDG PET/CT preliminary imaging of coronary artery inammation in
18
F-FDG uptake at the LMCA trifurcation in an Acute Coronary
c
18
F-NaF PET/CT imaging of plaque osteogenic
d
80])
into the vascular arena. 18F-NaF uptake is a useful marker of active calcication and does not represent the pre-existing calcium burden of a vessel (Fig.3.5).
Increased NaF uptake has been correlated with higher rates of prior cardiovascular
events, angina and Framingham risk scores [80]. Increased
18
F-NaF uptake has been associated with histological evidence of active calcication, macrophage inltration, apoptosis and necrosis [81]. It is further associated with other high-risk plaque features on intravascular ultrasound (IVUS) including positive remodeling, microcalcication, and necrotic core [81]. 18F-NaF PET-CT is a non-invasive method of imaging high-risk plaques, however its role in altering management needs further investigation.
3.8 Intravascular Imaging
3.8.1 Intravascular Ultrasound (IVUS)
Intravascular ultrasound (IVUS) involves the same principle as conventional ultra­sound but is able to take higher resolution images of atherosclerotic plaque. A trans­ducer produces sound waves at 20–40MHz, and the amplitude of the reections are
60
https://t.me/medicina_free
K. Rana et al.
digitised to produce gray-scale images [82]. Gray-scale IVUS has limited use in dening plaque morphology. In GS-IVUS, lipid-rich plaques have low-echogeneity, calcied plaques have high echogenicity with acoustic shadowing, brous plaques have intermediate echogeneity between the soft plaques and the echogenic calci­cations and mixed plaques have a combination of the above. However, many of the ndings in GS-IVUS are non-specic. For example, an area of echolucency may be attributable to one of several plaque features including lipids, necrotic zone, intra­mural haemorrhage, or thrombus [83].
To counter these issues, post-processing modules including virtual histology IVUS (VH-IVUS), iMAP-IVUS and integrated backscatter IVUS (IB-IVUS) have been developed. VH-IVUS uses the amplitude and frequency of the reected waves to gen­erate images. VH-IVUS has been shown to have reasonable accuracy (>90%) in iden­tifying brous tissue, bro-fatty regions, necrotic core and calcium-dense regions in plaques [84, 85]. VH-IVUS can also quantify plaque burden, lumen area, positive remodelling, and identify VH thin-cap broatheromas (Fig.3.6). VH-TCFAs have been dened as plaques with a necrotic core 10%in contact with the lumen without over­lying brous tissue and percent atheroma volume40% [86]. VH-IVUS characterised features including plaque burden >70%, minimal lumen area <4 mm2, VC-TCFAs, necrotic core area, dense calcium area and remodelling index have been associated with
Fig. 3.6 Intravascular ultrasound, virtual histology and OCT to highlight plaque morphology. (A) Grayscale IVUS, (B) Virtual Histology, (C) OCT imaging for four different types of plaque: (1) broatheroma, (2) calcied broatheroma, (3) thin-cap broatheroma, (4) calcied thin-cap bro­atheroma. (Reprinted from Gonzalo, Garcia-Garcia [110])